Expert Insights on the Appropriate Use of Noninvasive Tests for Fibrosis in Patients With MASH x.com/i/broadcasts/1…

📢 New in Frontline Gastro from Stuart Mcpherson Ian Rowe Tim Cross British Liver Trust 🧬 🧫 Hepatocellular carcinoma (HCC) is on the rise — but only 1 in 5 at-risk patients receive regular surveillance! 🛑 This new guidance sets minimum standards for improving early detection: 🗓️

#FDA: Liver Stiffness Measurement #LSM =accepted surrogate endpoint in MASLD #MASH🔗t.ly/kXUFU LSM predicts liver-related events #LRE =LBX Regression to LSM<10kPa -75% risk Progression to LSM≥10kPa +400% risk The Baveno Cooperation: an EASL Consortium Rule-of-5⃣ in cACLD ±20% LSM 🔀 ±50% risk

As we are a month or so into the new fellows starting to learn colonoscopy, I would like to reshare this Tweetorial on difficult colonoscopy. May our failures become our teachers, and our successes never blind us with overconfidence.

3. Practice models - Academic = stability, teaching, less comp leverage - Private = higher pay, but partnership is everything - Hybrid = hospital-employed, private practice feel Know which path you’re choosing, before you sign. 4. Red flags 🚩 “Don’t worry, we’ll put it in

Mehdi Hasan Also can be transmitted within households in early childhood, nail salons w/ poor sanitation, shared 🪥 ,🪒… sticky 🦠. But children who get infected develop CHRONIC HBV. I have cared for many patients in their 20s & 30s suffering from late complications such cirrhosis & cancer

This table, published before I was in medical school, is absolutely beautiful 😍 A summary of immunosuppresive medication used by practicing #transplant hepatologists NEJM. CWRU-GI/Case Western GI Fellowship UH Surgery Residents Case Western/UH IM Chiefs #livertwitter nejm.org/doi/full/10.10…

📜 ⚠️Check out Journal of Clinical and Experimental Hepatology Summary of data on 🔸Biopsy in ALF 🔸Dynamic scores in current era 🔸PLEX, CRRT 🔸ONSD , TCD 🔸🇮🇳 Concerns 🙌🏽 M PREMKUMAR Ajay Duseja Anand V Kulkarni Rakhi Maiwall Rohit Mehtani INASL Robert Fontana Shalimar jcehepatology.com/article/S0973-…

Varices begin their varices lives @ the portal vein, form connections, snake their over the stomach & up the esophagus If u fill a 🎈in the stomach & pull it up, u will smush the varices against the diaphragm THAT is why most have NEVER inflated the blakemore’s esophageal 🎈

‘Point-of-Care Ultrasound (POCUS) guided volume management... : Hepatology journals.lww.com/hep/abstract/9… Now online. #livertwitter Ajay Duseja Dr Nipun Verma Anand V Kulkarni HEPOCUS (Liver POCUS) Florent Artru Manhal Izzy Elliot Tapper POCUS to classify volume status in Cirrhosis & AKI Trajectory

Honored to have received the ACG 2025 Presidential Poster award for my poster, “Déjà Vu! A Case of Recurrent MASH 60 Days After Liver Transplantation”. Thankful for the mentorship of Adam Myer MD ACG LuisLaraMD

💡 Hepatitis B care is changing. The new #FGreview breaks down how the 2025 EASL guidelines reshape practice: ⚡️ Biomarkers > ALT alone ⚡️ Earlier treatment, even with low viral load ⚡️ Functional cure as the new benchmark ⚡️ MASLD now a key modifier ⚡️ Precision HCC

📰Disease-modifying effect of efruxifermin in compensated cirrhosis due to MASH: To miss the forest for the tree(s) 👉Cirrhosis regression only partially captures the potential therapeutic benefit of disease-modifying drugs in phase 3 🖇️ for explanation: authors.elsevier.com/sd/article/S25…

💯💯💯. Another hill I’ll die on. Patients come first. Don’t ever let anyone tell you otherwise. If you’re worth your salt, don’t work for systems or “leaders” who don’t put patients first.

GI polyps got you puzzled? 🫤 Dr. Salmaan Jawaid, MD breaks down the lumps and bumps of the GI tract — what they are, why they matter, and when to worry. #GITwitter #medtwitter

📚 Functional GI Disorders – High-Yield Pearls (Dr. Rawan Dayah) 🧠 Hirschsprung Disease •❌ Absent RAIR (Rectoanal Inhibitory Reflex) → 🔍 Suggests Hirschsprung 🚽 Constipation •🌀 Colonic Inertia → ❌ No HAPCs (High-Amplitude Propagating Contractions) on manometry •🎈

🔬 High-Yield Hereditary Cancer Syndromes (by Dr. Shweta Dhar): 1HBOC – BRCA1/2 2FAMMM – CDKN2A, CDK4 3Lynch (HNPCC) – MLH1, MSH2, MSH6, PMS2, EPCAM 4FAP – APC 5Others:  • Peutz-Jeghers – STK11  • MAP – MUTYH  • Juvenile Polyposis – SMAD4 6Cowden – PTEN

Cervical cancer screening remains low in liver transplant patients regardless of demographics: A single-center review Lizzie Aby, MD journals.lww.com/lt/citation/99…

The paradox of nitric oxide in cirrhosis and portal hypertension :- too little nitric oxide inside the liver, and too much outside it. Inside the liver, there’s actually nitric oxide deficiency. The endothelial cells in the hepatic sinusoids are dysfunctional ie their

🚨 Our findings from UNOS, published in AASLD Liver Transplantation Journal (LTxJournal) 1️⃣ TARE is overtaking TACE as the bridge to LT in HCC 📉 Lower waitlist dropout 🔬 >2x odds of complete pathologic necrosis ⏱️ Similar overall survival, often in fewer sessions ⚖️ Access gaps by insurance 👉